Department of Molecular Biology
Ausubel

Plant physiology
Chao

Biophysics & structural biology
Cell dynamics
Mitochondria
Diaz Cuadros

Developmental mechanisms
Metabolism
Hochedlinger

Developmental mechanisms
Epigenetics and Stem Cell Biology
Hung

Chemical biology
Infectious disease & immunity
Kaplan

Neurobiology & behavior
Kingston

Biophysics & structural biology
Developmental mechanisms
Epigenetics and Stem Cell Biology
Non-coding RNAs
Lee

Bioinformatics and Systems Biology
Epigenetics and Stem Cell Biology
Non-coding RNAs
Rare Diseases
Mootha

Bioinformatics and Systems Biology
Biophysics & structural biology
Genetics & population genetics
Metabolism
Mitochondria
Rare Diseases
Oettinger

Orefice

Neurobiology & behavior
Ruvkun

Non-coding RNAs
Origins of life & astrobiology
Sadreyev

Bioinformatics and Systems Biology
Sheen

Cell signaling
Plant physiology
Strecker

CRISPR-Cas systems
Subramanian

Biophysics & structural biology
Cell dynamics
Wattrus

Developmental mechanisms
Xavier

Cell signaling
Infectious disease & immunity
Events are generally limited to MGB personnel and their academic colleagues, and particularly those from our sister institutions in the greater Boston area
- Mar
- 28
- 2025
Regeneration in the Uterus
- Apr
- 8
- 2025
Epigenetics and Genomics Journal Club: A biophysical basis for the spreading behavior and limited diffusion of Xist

MGH and Harvard Medical School investigator Gary Ruvkun, PhD, has been named a recipient of the 2024 Nobel Prize in Physiology or Medicine for his role in the discovery of microRNA and its role in post-transcriptional gene regulation. He shares the award with his collaborator Victor Ambros, PhD, of the University of Massachusetts Medical School.
Over the past two decades, research into the potential of microRNAs for the diagnosis, prognosis and treatment of disease has expanded from the two original papers published by Ruvkun and Ambros in 1993 to 176,000 papers today.
Nobel Ceremony Video
Nobel Lecture
Press Release
Press Conference

The Company of Biologists spoke to Margarete over Teams to learn more about her transition to becoming a group leader and her philosophy for creating a positive lab environment.
Read More
